* * * ] Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.Fixed Price • February 25th, 2021 • MediWound Ltd. • Medicinal chemicals & botanical products
Amendment No. 1 to Settlement Agreement and Mutual General ReleaseMediWound Ltd. • February 25th, 2021 • Medicinal chemicals & botanical products
This Amendment No.1 to a Settlement Agreement and Mutual General Release (“Amendment”) is made effective of December 13, 2020 (the “Effective Date”) by end between Teva Pharmaceutical Industries Ltd. ("Teva"), on the one hand, and MediWound Ltd. ("MediWound"), on the other hand. Teva and MediWound are together referred to as the "Parties" and individually referred to as a “Party”.
